2024/10/18 22:00:00 | |
---|---|
Price | |
66.39 USD | |
Difference | -0.06% (-0.04) |
ISIN | US45337C1027 |
Symbol | INCY |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 11,808 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 65.44 USD (200) |
Ask (Ask size) | 67.20 USD (200) |
Open | 66.41 USD |
High | 66.95 USD |
Low | 65.90 USD |
Close (prev. day) | 66.43 USD |
VWAP | 66.355363 USD |
Volume (pcs) | 742,383 |
Trading volume | 49,252,381.22 |
Number of trades | 13,161 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 22:00:00 | |
---|---|
Price | |
66.39 USD | |
Difference | -0.06% (-0.04) |
ISIN | US45337C1027 |
Symbol | INCY |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 11,808 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 65.44 USD (200) |
Ask (Ask size) | 67.20 USD (200) |
Open | 66.41 USD |
High | 66.95 USD |
Low | 65.90 USD |
Close (prev. day) | 66.43 USD |
VWAP | 66.355363 USD |
Volume (pcs) | 742,383 |
Trading volume | 49,252,381.22 |
Number of trades | 13,161 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | +25.69% | +16.84% | +2.80% |
Perf (abs.) | +13.57 | +9.57 | +1.81 |
Beta | 0.26 | 0.35 | 0.50 |
Volatility | 27.08 | 27.00 | 26.65 |
Ø price 5 days | Ø volume 5 days (pcs.) | 66.14 USD (976,447) |
Ø price 30 days | Ø volume 30 days (pcs.) | 65.46 USD (1,779,408) |
Ø price 100 days | Ø volume 100 days (pcs.) | 63.41 USD (2,820,554) |
Ø price 250 days | Ø volume 250 days (pcs.) | 59.78 USD (2,290,915) |
YTD High | date | 70.36 USD (2024/07/25) |
YTD Low | date | 50.35 USD (2024/04/30) |
52 Weeks High | date | 70.36 USD (2024/07/25) |
52 Weeks Low | date | 50.27 USD (2023/10/31) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:26 | 61.12 EUR | 0.01 | 5 |
Stuttgart | 2024/10/18 | 21:31 | 60.98 EUR | 0.00 | 8 |
Nasdaq | 2024/10/18 | 22:00 | 66.39 USD | 49.25 | 13,161 |
Munich | 2024/10/18 | 08:01 | 60.98 EUR | 0.00 | 2 |
London Stock Exchange | 2023/02/16 | 18:03 | 79.48 USD | 0.10 | 1 |
Hanover | 2024/10/18 | 17:25 | 60.98 EUR | 0.00 | 4 |
Frankfurt | 2024/10/18 | 14:34 | 61.00 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | 2024/04/16 | 20:26 | 49.31 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/18 | 17:44 | 61.04 EUR | 0.00 | 1 |
Duesseldorf | 2024/10/18 | 19:31 | 60.98 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 21:52 | 60.98 EUR | 0.00 | 19 |
INCYTE CORP. |
- - |
1801 Augustine Cut-Off - 19803 Wilmington |
Telefon: +1-302-498-6700 |
Fax: + |
E-mail: - |
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE. |
Edmund Harrigan | Member of Board of Directors |
Jacqualyn Fouse | Member of Board of Directors |
Katherine High | Member of Board of Directors |
Otis Brawley | Member of Board of Directors |
Susanne Antonie Schaffert | Member of Board of Directors |
Jean-Jacques Bienaimé | Member of Board of Directors |
Julian Baker | Member of Board of Directors |
Paul Clancy | Member of Board of Directors |
Hervé Hoppenot | Chairman of Managing Board |
Barry P. Flannelly | Member of Executive Committee |
Lothar H. Finke | Member of Executive Committee |
Steven H. Stein | Member of Executive Committee |
Christiana Stamoulis | Member of Executive Committee |
Denise Brashear | Member of Executive Committee |
Jonathan E. Dickinson | Member of Executive Committee |
Michael Morrissey | Member of Executive Committee |
Pablo J. Cagnoni | Member of Executive Committee |
Paula J. Swain | Member of Executive Committee |
Sheila A. Denton | Member of Executive Committee |
Vijay Iyengar | Member of Executive Committee |
Xiaozhao Wang | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer